G-202
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for G-202, covering 2014-02-19 to 2017-02-24. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of G-202 in PSMA-Positive Glioblastoma [Phase 2]